Evaluated information for the NHS - NEW MEDICINES ON THE MARKET - June 2001 (PDF)
Linezolid.- It is active against a wide range of Gram-positive bacteria including MRSA, vancomycin-resistant enterococci (VRE) and penicillin-resistant pneumococci, but not against Gram-negative pathogens
http://www.ukmi.nhs.uk/NewMaterial/html/docs/linezolid.pdf
Esta web está
dirigida únicamente a profesionales sanitarios.
Web de tipo personal no ligada
a ninguna entidad pública ni privada | Quiénes
somos |
INFOMEDICAMENTO.NET - España -
Útima modificacion:
10/09/2011.